DSCAM and prostate carcinoma: In the clinical symptoms of prostate cancer patients, tumor size, AJCC stage, lymph node metastasis, Gleason score, and PSA, which indicated the progression and severity of the tumor, were all correlated with the expression of DSCAM-AS1.